These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6092758)

  • 1. Neuropathogenicity of a mutant of mouse hepatitis virus, JHM strain, derived from persistently infected DBT cells.
    Goto N; Takaoka M; Hirano N; Takahashi K; Fujiwara K
    Nihon Juigaku Zasshi; 1984 Aug; 46(4):459-65. PubMed ID: 6092758
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuropathogenicity of mutant strains of mouse hepatitis virus, 1A and 2C, from DBT cells persistently infected with JHM strain.
    Goto N; Makino S; Fujiwara K
    Adv Exp Med Biol; 1987; 218():439-40. PubMed ID: 2829556
    [No Abstract]   [Full Text] [Related]  

  • 3. Persistent infection with mouse hepatitis virus, JHM strain in DBT cell culture.
    Hirano N; Goto N; Makino S; Fujiwara K
    Adv Exp Med Biol; 1981; 142():301-8. PubMed ID: 6278888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathogenicity of mutant strains of mouse hepatitis virus, JHM.
    Goto N; Tsutsumi Y; Sato A; Fujiwara K
    Nihon Juigaku Zasshi; 1987 Oct; 49(5):779-86. PubMed ID: 2824906
    [No Abstract]   [Full Text] [Related]  

  • 5. Vacuolar encephalomyelopathy in mice induced by intracerebral inoculation with a coronavirus JHM-CC strain.
    Tsukamoto T; Iwasaki Y; Hirano N; Haga S
    Adv Exp Med Biol; 1990; 276():609-15. PubMed ID: 1966456
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic central nervous system demyelination in mice after JHM virus infection.
    Stohlman SA; Weiner LP
    Neurology; 1981 Jan; 31(1):38-44. PubMed ID: 6256683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JHM infections in rats as a model for acute and subacute demyelinating disease.
    Wege H; Koga M; Wege H; ter Meulen V
    Adv Exp Med Biol; 1981; 142():327-40. PubMed ID: 6278889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro models of demyelinating diseases: tropism of the JHM strain of murine hepatitis virus for cells of glial origin.
    Lucas A; Flintoff W; Anderson R; Percy D; Coulter M; Dales S
    Cell; 1977 Oct; 12(2):553-60. PubMed ID: 199356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine coronaviruses: isolation and characterization of two plaque morphology variants of the JHM neurotropic strain.
    Stohlman SA; Brayton PR; Fleming JO; Weiner LP; Lai MM
    J Gen Virol; 1982 Dec; 63(2):265-75. PubMed ID: 6296277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronavirus JHM induced demyelinating disease: specific domains on the E2-protein are associated with neurovirulence.
    Wege H; Winter J; Massa P; Dörries R; ter Meulen V
    Adv Exp Med Biol; 1987; 218():307-20. PubMed ID: 2449042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contributions of CD8+ T cells and viral spread to demyelinating disease.
    Marten NW; Stohlman SA; Atkinson RD; Hinton DR; Fleming JO; Bergmann CC
    J Immunol; 2000 Apr; 164(8):4080-8. PubMed ID: 10754301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to infection with mouse hepatitis virus (MHV) in the cell clones derived from persistently infected DBT cells with the JHM strain of MHV.
    Maeda A; Kon Y; Watanabe T; Hayashi M
    J Vet Med Sci; 1997 Jul; 59(7):545-9. PubMed ID: 9271448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of CTL mutants in demyelination induced by mouse hepatitis virus, strain JHM.
    Perlman S; Pewe L
    Adv Exp Med Biol; 1998; 440():515-9. PubMed ID: 9782323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postinflammatory remyelination in the spinal cord of mice infected with mouse hepatitis virus, JHM strain.
    Takahashi K; Goto N; Matsubara Y; Fujiwara K
    Jpn J Exp Med; 1987 Jun; 57(3):145-51. PubMed ID: 2824884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse hepatitis virus-induced recurrent demyelination. A preliminary report.
    Herndon RM; Griffin DE; McCormick U; Weiner LP
    Arch Neurol; 1975 Jan; 32(1):32-5. PubMed ID: 163630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host and virus factors associated with CNS cellular tropism leading to encephalomyelitis or demyelination induced by the JHM strain of mouse hepatitis virus.
    Knobler RL; Haspel MV; Dubois-Dalcq M; Lampert PW; Oldstone MB
    Adv Exp Med Biol; 1981; 142():341-8. PubMed ID: 6278890
    [No Abstract]   [Full Text] [Related]  

  • 17. Contributions of the viral genetic background and a single amino acid substitution in an immunodominant CD8+ T-cell epitope to murine coronavirus neurovirulence.
    MacNamara KC; Chua MM; Phillips JJ; Weiss SR
    J Virol; 2005 Jul; 79(14):9108-18. PubMed ID: 15994805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nasoencephalopathy of mice infected intrananasally with a mouse hepatitis virus, JHM strain.
    Goto N; Hirano N; Aiuchi M; Hayashi T; Fujiwara K
    Jpn J Exp Med; 1977 Feb; 47(1):59-70. PubMed ID: 192927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterologous response of antiserum-treated cell clones from a persistently infected DBT cell line to mouse hepatitis virus.
    Makino S; Taguchi F; Fujiwara K; Hayami M
    Jpn J Exp Med; 1982 Dec; 52(6):297-302. PubMed ID: 6302351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo and in vitro models of demyelinating diseases.
    Sorensen O; Coulter-Mackie M; Percy D; Dales S
    Adv Exp Med Biol; 1981; 142():271-86. PubMed ID: 6278886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.